CN101801392B - 含有脂膜酸的用于治疗胸腔积液或气胸的组合物 - Google Patents

含有脂膜酸的用于治疗胸腔积液或气胸的组合物 Download PDF

Info

Publication number
CN101801392B
CN101801392B CN2008801059024A CN200880105902A CN101801392B CN 101801392 B CN101801392 B CN 101801392B CN 2008801059024 A CN2008801059024 A CN 2008801059024A CN 200880105902 A CN200880105902 A CN 200880105902A CN 101801392 B CN101801392 B CN 101801392B
Authority
CN
China
Prior art keywords
pneumothorax
pleural effusion
lipoic acid
pleural
micrograms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2008801059024A
Other languages
English (en)
Chinese (zh)
Other versions
CN101801392A (zh
Inventor
R·J·O·戴维斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford University Innovation Ltd
Original Assignee
Oxford University Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford University Innovation Ltd filed Critical Oxford University Innovation Ltd
Publication of CN101801392A publication Critical patent/CN101801392A/zh
Application granted granted Critical
Publication of CN101801392B publication Critical patent/CN101801392B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/739—Lipopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN2008801059024A 2007-09-07 2008-09-08 含有脂膜酸的用于治疗胸腔积液或气胸的组合物 Expired - Fee Related CN101801392B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0717442.8 2007-09-07
GBGB0717442.8A GB0717442D0 (en) 2007-09-07 2007-09-07 Compositions and uses thereof
PCT/GB2008/003019 WO2009030929A1 (en) 2007-09-07 2008-09-08 Compositions comprising lipoteichoic acid for use in treating pleural effusion or pneumothorax

Publications (2)

Publication Number Publication Date
CN101801392A CN101801392A (zh) 2010-08-11
CN101801392B true CN101801392B (zh) 2012-09-05

Family

ID=38640413

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2008801059024A Expired - Fee Related CN101801392B (zh) 2007-09-07 2008-09-08 含有脂膜酸的用于治疗胸腔积液或气胸的组合物

Country Status (8)

Country Link
US (1) US8536139B2 (cg-RX-API-DMAC7.html)
EP (1) EP2194991B1 (cg-RX-API-DMAC7.html)
JP (1) JP5623906B2 (cg-RX-API-DMAC7.html)
CN (1) CN101801392B (cg-RX-API-DMAC7.html)
AT (1) ATE545424T1 (cg-RX-API-DMAC7.html)
ES (1) ES2382501T3 (cg-RX-API-DMAC7.html)
GB (1) GB0717442D0 (cg-RX-API-DMAC7.html)
WO (1) WO2009030929A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE8611854U1 (de) 1986-04-30 1986-06-19 Stahl Gmbh & Co Maschinenfabrik, 7140 Ludwigsburg Kombinierte Vierbruchfalzmaschine
EP2545909A1 (en) * 2011-07-12 2013-01-16 Lunamed AG Combination of D-Amino Acids and Lipoteichoic Acid
EP2589387A1 (en) 2011-11-04 2013-05-08 Lunamed AG Use of a teichoic acid for the treatment of malignant liquor cerebrospinalis in the brain
EP2589388A1 (en) 2011-11-04 2013-05-08 Lunamed AG Use of a Teichoic acid for the treatment of malignant ascites
CN103961512A (zh) * 2014-06-02 2014-08-06 王志红 一种用于创伤性气胸护理的中药制剂及制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1173206A (zh) * 1995-01-30 1998-02-11 彼得·特鲁格 含有链球菌脂磷壁酸质的抗肿瘤和抗胆固醇制剂

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005030133A2 (en) 2003-09-22 2005-04-07 Yale University Treatment with agonists of toll-like receptors
WO2008048560A2 (en) 2006-10-16 2008-04-24 Yale University Toll-like receptor agonist regulation of vegf-induced tissue responses

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1173206A (zh) * 1995-01-30 1998-02-11 彼得·特鲁格 含有链球菌脂磷壁酸质的抗肿瘤和抗胆固醇制剂

Also Published As

Publication number Publication date
EP2194991A1 (en) 2010-06-16
WO2009030929A1 (en) 2009-03-12
JP5623906B2 (ja) 2014-11-12
JP2010538054A (ja) 2010-12-09
EP2194991B1 (en) 2012-02-15
ATE545424T1 (de) 2012-03-15
GB0717442D0 (en) 2007-10-17
ES2382501T3 (es) 2012-06-08
US8536139B2 (en) 2013-09-17
US20110059908A1 (en) 2011-03-10
CN101801392A (zh) 2010-08-11

Similar Documents

Publication Publication Date Title
RU2672871C2 (ru) Применение левоцетиризина и монтелукаста при лечении травматических повреждений
WO2012047674A2 (en) Methods and compositions for disease treatment using inhalation
Spengler et al. Novel therapeutic roles for surfactant-inositols and-phosphatidylglycerols in a neonatal piglet ARDS model: A translational study
CN101801392A (zh) 含有脂膜酸的用于治疗胸腔积液或气胸的组合物
Chapman et al. The ineffectiveness of steroid therapy in treating aspiration of hydrochloric acid
KR20190090046A (ko) 피부과학적 병리의 치료
Stanley et al. Effect of betamethasone and betamethasone with neomycin nasal drops on human nasal mucociliary clearance and ciliary beat frequency.
Assouline et al. Intravenous iron supplementation after liver surgery: impact on anemia, iron, and hepcidin levels—a randomized controlled trial
Ziegler et al. S1PR3 agonism and S1P lyase inhibition rescue mice in the severe state of experimental sepsis
US20060148712A1 (en) Monocyte chemoattractant activity of galectin-3
Karadag et al. Pulmonary fibrosis developed secondary to methotrexate use in a patient with psoriasis vulgaris
WO2022003443A1 (ko) 양이온성 리포좀을 포함하는 사포닌의 용혈 억제용 조성물
EA032116B1 (ru) Новое применение n,n-бис-2-меркаптоэтил-изофталамида
JP2019508458A (ja) 重症市中肺炎の処置
Akhavan et al. The role of electrical impedance tomography for monitoring during bronchoscopy: A case report
JP6912875B2 (ja) ErbB4+炎症性マクロファージによって媒介される疾患の治療方法
US12616741B2 (en) Therapeutic combination comprising a pulmonary surfactant and a steroid for the prophylaxis of BPD
US20250325598A1 (en) Immunobiotics for preventing bacterial pneumonia and methods of using the same
RU2609865C1 (ru) Способ лечения детей с острыми респираторными инфекциями на фоне вторичной иммунной недостаточности
US10464998B2 (en) Anti-LPS enriched immunoglobulin for use in treatment and/or prophylaxis of fibrosis
Bhandari et al. Novel Immunomodulatory Compounds to Prevent Bronchopulmonary Dysplasia
IT201800006455A1 (it) Nuovo utilizzo degli inibitori della monoammino ossidasi B
Petrusevska-Marinkovic et al. Avascular Necrosis of the Hip Joint and Femoral Head Related with Long COVID-19 or Post-COVID-19: Case Report Study
PONS et al. EVALUATION OF AEROSOL-NEGATIVE PRESSURE THERAPY: Given Once Daily in Chronic Purulent Sinusitis
JP2004533417A (ja) 上皮/基質間付着力の増強により改善される喘息、嚢胞性線維症、およびインフルエンザなどの疾病の治療におけるプロピオン酸フルチカゾンの使用

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20120905

Termination date: 20170908

CF01 Termination of patent right due to non-payment of annual fee